Calcification is commonly associated with atherosclerosis, and it has
important clinical implications, especially in coronary arteries. The
mineral has been identified as the same mineral as in bone, hydroxyapa
tite, and several features of its development suggest a mechanism simi
lar to osteogenesis and not merely passive precipitation. The artery w
ad has been shown to contain several bone-related proteins, including
those for osteopontin, osteonectin, and osteocalcin, as well as proteo
glycan cove proteins homologous with bone biglycan. Our laboratory rec
ently demonstrated that a potent osteogenic differentiation factor, bo
ne morphogenetic protein 2a, is expressed in calcified human atheroscl
erotic lesions, suggesting that arterial calcification may be initiate
d by an osteogenic differentiation. In addition, a cell capable of cal
cium mineral formation in vitro has been isolated from bovine and huma
n aorta and identified by immunostaining as having a surface marker ch
aracteristic of microvascular pericytes. These findings suggest the po
ssibility that plaque calcification develops when ;a signal from ather
osclerotic plaque or a factor associated with atherosclerosis induces
expression of bone morphogenetic protein, leading to osteogenic differ
entiation of pluripotential, pericytelike cells located in the arteria
l intima, which then produce bonelike matrix and hydroxyapatite minera
l. These findings also raise questions as to whether osteogenic-promot
ing factors used to prevent osteoporosis may also increase risk of art
erial calcification.